CHA ÀǰúÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀçÈ­
  • ºÐ´çÂ÷º´¿øÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °ß°üÀý/½½°üÀý
  • Á÷ À§: ±³¼ö(ºÐ´çÂ÷º´¿øÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
286 (±¹¿Ü)SCI Sarcopenia Index Is Correlated with Osteoporosis in Patients with Chronic Kidney Disease
285 (±¹¿Ü)SCI Network Analysis of Legg?Calve?Perthes Disease and Its Comorbidities
284 (±¹¿Ü)SCI Therapeutic role of aripiprazole in cartilage defects explored through a drug repurposing approach
283 (±¹¿Ü)SCI Hybrid nanoparticle engineered with transforming growth factor-¥â1-overexpressed extracellular vesicle and cartilage-targeted anti-inflammatory liposome for osteoarthritis
282 (±¹¿Ü)SCI Long-Term Mental Health Outcomes of Bronchopulmonary Dysplasia in Neonates: An 18-Year National Cohort Study
281 (±¹¿Ü)SCI Auranofin as a Novel Anticancer Drug for Anaplastic Thyroid Cancer
280 (±¹¿Ü)SCI Association of fluoride exposure with disease burden and neurodevelopment outcomes in children in South Korea
279 (±¹¿Ü)SCI Multifunctional extracellular vesicles and edaravone-loaded scaffolds for kidney tissue regeneration by activating GDNF/RET pathway
278 (±¹¿Ü)SCI Prognostic value of body composition measures in breast cancer patients treated with chemotherapy
277 (±¹¿Ü)SCI Analyses of Osteogenesis Imperfecta in South Korea Using the Nationwide Health Insurance Service Claim Data: A Propensity Score-Matched Study
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾Çհǰ­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729